These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12874365)

  • 21. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
    Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
    Uddin T; Aktar A; Xu P; Johnson RA; Rahman MA; Leung DT; Afrin S; Akter A; Alam MM; Rahman A; Chowdhury F; Khan AI; Bhuiyan TR; Bufano MK; Rashu R; Yu Y; Wu-Freeman Y; Harris JB; LaRocque RC; Charles RC; Kováč P; Calderwood SB; Ryan ET; Qadri F
    Am J Trop Med Hyg; 2014 May; 90(5):873-81. PubMed ID: 24686738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.
    Qadri F; Wennerås C; Albert MJ; Hossain J; Mannoor K; Begum YA; Mohi G; Salam MA; Sack RB; Svennerholm AM
    Infect Immun; 1997 Sep; 65(9):3571-6. PubMed ID: 9284121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    Venkatesan MM; Ballou C; Barnoy S; McNeal M; El-Khorazaty J; Frenck R; Baqar S
    PLoS One; 2021; 16(11):e0259361. PubMed ID: 34793505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients.
    Svennerholm AM; Levine MM; Holmgren J
    Infect Immun; 1984 Sep; 45(3):792-4. PubMed ID: 6469362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination.
    Rijpkema SG; Jansen WH; Gielen H; Guinée PA
    Microb Pathog; 1987 Nov; 3(5):365-75. PubMed ID: 2462153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.
    Patel SM; Rahman MA; Mohasin M; Riyadh MA; Leung DT; Alam MM; Chowdhury F; Khan AI; Weil AA; Aktar A; Nazim M; LaRocque RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2012 Jun; 19(6):842-8. PubMed ID: 22518009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.
    Johnson RA; Uddin T; Aktar A; Mohasin M; Alam MM; Chowdhury F; Harris JB; LaRocque RC; Bufano MK; Yu Y; Wu-Freeman Y; Leung DT; Sarracino D; Krastins B; Charles RC; Xu P; Kovác P; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 Nov; 19(11):1712-21. PubMed ID: 22993410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
    Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
    Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
    Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.
    Externest D; Meckelein B; Schmidt MA; Frey A
    Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
    Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
    Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues.
    Qadri F; Mäkelä PH; Holmgren J; Albert MJ; Mannoor K; Kantele A; Saha D; Salam MA; Kantele JM
    J Infect Dis; 1998 Jun; 177(6):1594-9. PubMed ID: 9607838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
    Viret JF; Favre D; Wegmüller B; Herzog C; Que JU; Cryz SJ; Lang AB
    Infect Immun; 1999 Jul; 67(7):3680-5. PubMed ID: 10377160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.